Neuralink’s Blindsight Receives Fda Breakthrough Status, To Restore Vision For The Blind

Elon Musk’s Neuralink has announced it received “breakthrough device” clearance from the U.S. Food and Drug Administration. An FDA breakthrough device is a voluntary program for certain medical devices that provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions. The billionaire claimed on X that the product called Blindsight, “will enable even those who have lost both eyes and their optic nerve to see,” provided the visual cortex is intact. He added that “it will even enable those who have been blind from birth to see for the first time.” The Blindsight device from Neuralink will enable even those who have lost both eyes and their optic nerve to see. Provided the visual cortex is intact, it will even enable those who have been blind from birth to see for the first time. To set expectations correctly, the vision… https://t.co/MYLHNcPrw6 pic.twitter.com/RAenDpd3fx — Elon Musk (@elonmusk) September 17, 2024 However, this does not mean the brain chip startup has developed a cure for blindness, as it remains in the early stages and the process is complex.